Our results demonstrated that pravastatin decreased the hypertension, urine protein level, and the incidence of FGR of PE-like rat model by ameliorating the exacerbated TLR4/NF-κB activation in placenta from LPS rats’ model. This evidence concerns the gene NFKB1 and hypertensive disorder.